| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |